CDC approves COVID-19 vaccine for children under 5
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On June 18, the U.S. Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 6 months to 5 years old, following a recommendation from the Food and Drug Administration (FDA). This approval now expands vaccine eligibility for the use of the two primary COVID-19 vaccines in the U.S. – Pfizer-BioNTech and Moderna – to nearly 20 million additional children, and makes all Americans aged 6 months and older eligible to receive a COVID-19 vaccination.
The White House has indicated that the federal government has an initial supply of approximately 10 million doses of pediatric vaccines, for which states began placing orders last month. CDC has indicated that the distribution of pediatric vaccinations for children aged 5 and under has already begun and shots will be available at local pediatric practices, pharmacies, Federally Qualified Health Centers, local health departments, clinics and other locations as early as June 20. Earlier this month, the agency updated it’s Pediatric COVID-19 Vaccination Operational Planning Guide with information on dosage ordering and a pediatric readiness checklist for local distribution.
As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of nearly 600 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
Additional Resources
Resource
The County Role in Vaccines
Related News
HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.
Public-private partnership creates ‘one-stop shop’ to improve community wellness
The South Philadelphia Community Health and Literacy Center is a “one-stop shop” the city and the children’s hospital created to improve community wellness and make it easier for people to get their needs met.